首頁 > 市場調查報告書 > 醫療設備

感測器生技設備

市場調查報告書

商品編碼

2037528

生物感測器市場預測至2034年—按產品類型、生物辨識元件、技術、應用、最終用戶和地區分類的全球分析

Biosensors Market Forecasts to 2034 - Global Analysis By Product Type, Biological Recognition Element, Technology, Application, End User, and By Geography

出版日期: 2026年05月11日 | 出版商:

Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

根據 Stratistics MRC 預測，全球生物感測器市場預計到 2026 年將達到 385 億美元，並在預測期內以 8.1% 的複合年成長率成長，到 2034 年將達到 719 億美元。

生物感測器是一種分析儀器，它將生物識別元件與物理化學換能器結合，用於檢測特定的目標物質，從而實現對生物或化學物質的快速、高靈敏度測量。這些儀器透過提供即時、便攜且經濟高效的分析，正在革新眾多領域的診斷和監測方式。市場涵蓋了廣泛的技術，包括電化學、光學和壓電感測器，其應用範圍延伸至醫療保健、食品安全、環境保護和農業監測等領域。

慢性病盛行率不斷上升以及持續監測的必要性

全球糖尿病、心血管疾病和其他慢性疾病的日益增多，使得基於生物感測器的診斷工具需求空前高漲。患者需要頻繁監測血糖值、膽固醇和其他生物標記物，這推動了穿戴式和照護現場生物感測器的應用，這些設備便捷且能提供即時數據。傳統的實驗室檢測方法正逐漸被快速、易用的生物感測器設備所取代，使患者能夠在家中進行健康管理。透過早期檢測和持續監測，醫療保健系統受益於住院成本的降低和患者預後的改善，生物感測器技術正成為已開發國家和新興國家現代慢性病管理策略的基礎。

高昂的製造成本和校準要求

高精度生物感測器的製造涉及先進的微加工技術、專用生物試劑和嚴格的品管流程，所有這些都推高了製造成本。許多生物感測器由於使用了生物成分，需要定期校準，且保存期限有限，這導致終端用戶和醫療機構持續承擔成本。這些因素阻礙了生物感測器在價格敏感地區和預算緊張的小規模醫療機構的市場滲透。此外，將生物辨識元件與電子感測器整合的技術複雜性限制了合格製造商的數量，從而削弱了可能降低價格和加速創新週期的競爭壓力。

穿戴式科技及其與智慧型手機的整合

智慧型手錶、健身追蹤器和行動醫療應用程式的普及，為生物感測器在消費者日常生活中的應用開啟了新的可能性。微型化和軟性電子產品的進步，使得將生物感測功能無縫整合到穿戴式裝置中成為可能，從而能夠持續監測生命徵象、水分含量和代謝指標。與智慧型手機的連接，將這些設備轉變為個人健康管理平台，數據可自動同步到雲端分析系統並與醫療服務提供者共用。家用電子電器與醫療診斷的融合，為那些開發非侵入式或微創生物感測器的公司創造了巨大的商機，這些感測器能夠吸引那些注重健康、尋求主動健康管理的消費者。

嚴格的監管核准流程

將新型生物感測器設備推向市場需要經過FDA和EMA等監管機構的嚴格檢驗，這會造成巨大的時間和成本障礙。臨床試驗必須證明其在不同患者群體中的準確性、可靠性和安全性，而這些試驗通常需要數年才能完成。生產流程或組件採購的任何變更都可能引發額外的監管審查，從而限制創新的柔軟性。擁有前景廣闊技術的中小型企業可能難以應對這種複雜的環境，這可能導致競爭減少。圍繞基於軟體的生物感測器和人工智慧驅動分析的監管不確定性進一步增加了複雜性，可能導致產品上市延遲，並增加市場參與企業的開發風險。

新冠疫情的影響：

新冠疫情大大加速了生物感測器的應用，使快速檢測成為全球公共衛生領域的重中之重。用於檢測病毒抗原和抗體的照護現場（POC）生物感測器的需求激增，世界各國政府和醫療系統都在尋求快速且擴充性的檢測解決方案。供應鏈迅速調整，生產了數百萬條試紙和攜帶式讀數器，展現了其製造擴充性。此次危機也推動了穿戴式生物感測器的創新，用於遠端患者監護，從而降低了醫院的感染風險。疫情過後，隨著醫療服務提供者認知到分散式檢查和持續監測的價值，這一發展勢頭仍在持續，感染疾病控制和一般診斷領域生物感測器技術的潛在市場也在不斷擴大。

在預測期內，醫療應用領域預計將佔據最大的市場佔有率。

預計在預測期內，醫療應用領域將佔據最大的市場佔有率，這主要得益於生物感測器在疾病診斷、病患監測和個人化醫療中發揮的關鍵作用。血糖監測（用於糖尿病管理）仍然是最大的單一應用領域，數百萬患者每天都在使用連續血糖監測儀。心臟生物標記、感染疾病檢測和癌症篩檢是快速成長的細分領域。在醫院、診所和居家醫療環境中，人們越來越依賴生物感測器進行就地檢驗，從而快速獲得結果，無需等待檢查室檢測。全球人口老化和預防醫學的興起將進一步鞏固醫療應用領域在整個預測期內的主導地位。

在預測期內，居家醫療領域預計將呈現最高的複合年成長率。

在預測期內，居家醫療領域預計將呈現最高的成長率，這反映出醫療模式正朝著分散式、以患者為中心的模式轉變。專為家庭使用而設計的生物感測器使人們能夠監測慢性疾病、追蹤用藥依從性並檢測早期預警訊號，而無需頻繁就醫。使用者友善介面、智慧型手機整合和非侵入式採樣方法等方面的技術進步，使得家庭生物感測技術越來越容易被老年人和精通技術的用戶所接受。醫療保健系統正在推動這一轉變，以減少再入院率並降低整體醫療保健成本。遠端醫療服務的擴展和患者自我照護參與度的提高，正在顯著加速生物感測器在居家醫療的應用。

市佔率最大的地區：

在整個預測期內，北美預計將保持最大的市場佔有率，這得益於其先進的醫療保健基礎設施、高額的醫療費用支出和健全的法規結構。該地區對醫學研究和生物技術創新的巨額投資正在推動生物感測器的持續發展。總部位於美國的主要行業參與者擁有廣泛的分銷網路，並與醫療保健提供者建立了牢固的合作關係。糖尿病監測和診斷檢測的優惠報銷政策正在加速其在臨床和家庭環境中的應用。大眾對預防醫學意識的提高以及穿戴式健康技術的普及也將進一步鞏固北美在整個預測期內的市場主導地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於醫療保健覆蓋範圍的快速擴大、可支配收入的增加以及慢性病負擔的加重。包括中國、印度和東南亞國家在內的各國正在大力投資，以實現醫療基礎設施現代化並推動照護現場。大規模的人口基數以及糖尿病和心血管疾病盛行率的不斷上升，使得對價格合理的生物感測器解決方案的需求龐大。政府支持國內醫療設備製造和向數位化醫療轉型的措施正在加速市場成長。隨著國際製造商建立本地生產基地，以及區域企業開發更具成本效益的替代方案，亞太地區正成為生物感測器應用成長最快的地區。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

企業概況
- 對其他市場參與者（最多 3 家公司）進行全面分析
- 對主要公司進行SWOT分析（最多3家公司）
區域分類
- 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
競爭性標竿分析
- 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 比利時
- 瑞典
- 瑞士
- 波蘭
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 印尼
- 泰國
- 馬來西亞
- 新加坡
- 越南
- 其他亞太國家
南美洲
- 巴西
- 阿根廷
- 哥倫比亞
- 智利
- 秘魯
- 其他南美國家
世界其他地區（RoW）
- 中東
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 卡達
  - 以色列
  - 其他中東國家
- 非洲
  - 南非
  - 埃及
  - 摩洛哥
  - 其他非洲國家

第11章策略市場資訊

工業價值網路和供應鏈評估
空白區域和機會地圖
產品演進與市場生命週期分析
通路、經銷商和打入市場策略的評估

第12章產業趨勢與策略舉措

併購
夥伴關係、聯盟和合資企業
新產品發布和認證
擴大生產能力和投資
其他策略舉措

第13章：公司簡介

Abbott Laboratories
F. Hoffmann-La Roche Ltd
Medtronic plc
Siemens Healthineers AG
Danaher Corporation
Thermo Fisher Scientific Inc
Nova Biomedical Corporation
Bio-Rad Laboratories Inc
AgaMatrix Inc
Dexcom Inc
Ascensia Diabetes Care Holdings AG
ARKRAY Inc
LifeScan Inc
Senseonics Holdings Inc
Biosensors International Group Ltd

簡介目錄圖表

Product Code: SMRC35943

According to Stratistics MRC, the Global Biosensors Market is accounted for $38.5 billion in 2026 and is expected to reach $71.9 billion by 2034 growing at a CAGR of 8.1% during the forecast period. Biosensors are analytical devices that combine a biological recognition element with a physicochemical transducer to detect specific analytes, enabling rapid and sensitive measurement of biological or chemical substances. These devices are revolutionizing diagnostics and monitoring across multiple sectors by offering real-time, portable, and cost-effective analysis. The market encompasses a wide range of technologies including electrochemical, optical, and piezoelectric biosensors, with applications spanning healthcare, food safety, environmental protection, and agricultural monitoring.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases and need for continuous monitoring

The global increase in diabetes, cardiovascular disorders, and other chronic conditions is creating unprecedented demand for biosensor-based diagnostic tools. Patients require frequent monitoring of blood glucose, cholesterol, and other biomarkers, driving adoption of wearable and point-of-care biosensors that offer convenience and real-time data. Traditional laboratory testing methods are being replaced by rapid, user-friendly biosensor devices that enable patients to manage their conditions at home. Healthcare systems benefit from reduced hospitalization costs and improved patient outcomes through early detection and continuous monitoring, making biosensor technology a cornerstone of modern chronic disease management strategies across developed and emerging economies.

Restraint:

High manufacturing costs and calibration requirements

The production of high-precision biosensors involves sophisticated microfabrication techniques, specialized bioreagents, and stringent quality control processes that drive up manufacturing expenses. Many biosensors require regular calibration and have limited shelf life due to the biological components used, creating recurring costs for end users and healthcare facilities. These factors restrict market penetration in price-sensitive regions and smaller healthcare settings where budget constraints are severe. The technical complexity of integrating biological recognition elements with electronic transducers also limits the number of qualified manufacturers, reducing competitive pressure that might otherwise drive down prices and accelerate innovation cycles.

Opportunity:

Integration with wearable technology and smartphones

The proliferation of smartwatches, fitness trackers, and mobile health applications is opening new frontiers for biosensor deployment in everyday consumer settings. Advances in miniaturization and flexible electronics enable seamless integration of biosensing capabilities into wearable devices, allowing continuous monitoring of vital signs, hydration levels, and metabolic markers. Smartphone connectivity transforms these devices into personal health management platforms, with data automatically synced to cloud-based analytics and shared with healthcare providers. This convergence of consumer electronics and medical diagnostics creates substantial opportunities for companies developing non-invasive or minimally invasive biosensors that appeal to health-conscious consumers seeking proactive wellness management.

Threat:

Stringent regulatory approval processes

The pathway to market for new biosensor devices involves rigorous validation requirements from agencies such as the FDA and EMA, creating significant time and cost barriers. Clinical trials must demonstrate accuracy, reliability, and safety across diverse patient populations, often taking several years to complete. Changes in manufacturing processes or component sourcing can trigger additional regulatory reviews, limiting flexibility for innovation. Smaller companies with promising technologies may fail to navigate this complex landscape, reducing competition. Regulatory uncertainty regarding software-based biosensors and artificial intelligence interpretation adds further complexity, potentially delaying product launches and increasing development risks for market participants.

Covid-19 Impact:

The COVID-19 pandemic dramatically accelerated biosensor adoption as rapid testing became a public health priority worldwide. Demand surged for point-of-care biosensors detecting viral antigens and antibodies, with governments and healthcare systems seeking quick, scalable testing solutions. Supply chains adapted to produce millions of test strips and portable readers, demonstrating manufacturing scalability. The crisis also spurred innovation in wearable biosensors for remote patient monitoring, reducing hospital exposure risks. Post-pandemic, this momentum continues as healthcare providers recognize the value of decentralized testing and continuous monitoring, permanently expanding the addressable market for biosensor technologies across infectious disease management and general diagnostics.

The Medical applications segment is expected to be the largest during the forecast period

The Medical applications segment is expected to account for the largest market share during the forecast period, driven by the critical role of biosensors in disease diagnosis, patient monitoring, and personalized medicine. Glucose monitoring for diabetes management remains the single largest application, with millions of patients using continuous glucose monitors daily. Cardiac biomarkers, infectious disease detection, and cancer screening represent rapidly growing subsegments. Hospitals, clinics, and home healthcare settings increasingly rely on biosensors for point-of-care testing that delivers rapid results without laboratory delays. The aging global population and the shift toward preventive healthcare further reinforce medical applications as the dominant segment throughout the forecast timeline.

The Home healthcare segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Home healthcare segment is predicted to witness the highest growth rate, reflecting the broader movement toward decentralized, patient-centric care models. Biosensors designed for home use enable individuals to monitor chronic conditions, track medication adherence, and detect early warning signs without frequent clinic visits. Technological advances in user-friendly interfaces, smartphone integration, and non-invasive sampling methods make home-based biosensing increasingly accessible to elderly and non-technical users. Healthcare systems encourage this shift to reduce hospital readmissions and lower overall treatment costs. As telehealth services expand and patients become more engaged in self-management, home healthcare adoption of biosensors accelerates substantially.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by advanced healthcare infrastructure, high healthcare spending, and strong regulatory frameworks. The region's substantial investment in medical research and biotechnology innovation drives continuous biosensor development. Major industry players headquartered in the United States maintain extensive distribution networks and strong relationships with healthcare providers. Favorable reimbursement policies for diabetes monitoring and diagnostic testing encourage adoption across both clinical and home settings. Public awareness of preventive healthcare and the availability of wearable health technologies further contribute to North America's dominant position throughout the forecast period.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fueled by rapidly expanding healthcare access, rising disposable incomes, and growing burden of chronic diseases. Countries including China, India, and Southeast Asian nations are investing heavily in modernizing healthcare infrastructure and promoting point-of-care diagnostics. Large populations with increasing diabetes and cardiovascular disease prevalence create massive demand for affordable biosensor solutions. Government initiatives supporting domestic medical device manufacturing and digital health transformation accelerate market growth. As international manufacturers establish local production facilities and regional companies develop cost-effective alternatives, Asia Pacific emerges as the fastest-growing region for biosensor adoption.

Key players in the market

Some of the key players in Biosensors Market include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Medtronic plc, Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc, Nova Biomedical Corporation, Bio-Rad Laboratories Inc, AgaMatrix Inc, Dexcom Inc, Ascensia Diabetes Care Holdings AG, ARKRAY Inc, LifeScan Inc, Senseonics Holdings Inc, and Biosensors International Group Ltd.

Key Developments:

In March 2026, Abbott expanded its partnership with various health tech firms to integrate its FreeStyle Libre biosensor data into enterprise-level employee wellness programs, focusing on metabolic health tracking for non-diabetics.

In March 2026, Medtronic announced the successful implementation of its latest AI-driven models within its insertable cardiac monitors (ICMs), reducing false-positive arrhythmia detections by nearly 30%.

In September 2025, Senseonics enrolled the first patients in its Gemini clinical trial, testing a self-powered, battery-enabled sensor that eliminates the need for an external transmitter.

Product Types Covered:

Wearable biosensors
Non-wearable biosensors
Implantable biosensors

Biological Recognition Elements Covered:

Enzymatic biosensors
Non-enzymatic biosensors
DNA biosensors
Immunosensors
Microbial biosensors

Technologies Covered:

Electrochemical biosensors
Optical biosensors
Piezoelectric biosensors
Thermal biosensors
Nanomechanical biosensors

Applications Covered:

Medical applications
Food and beverage testing
Environmental monitoring
Agriculture
Biodefense and security

End Users Covered:

Hospitals and clinics
Diagnostic laboratories
Home healthcare
Research and academic institutes
Pharmaceutical and biotechnology companies

Regions Covered:

North America
- United States
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Netherlands
- Belgium
- Sweden
- Switzerland
- Poland
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Vietnam
- Rest of Asia Pacific
South America
- Brazil
- Argentina
- Colombia
- Chile
- Peru
- Rest of South America
Rest of the World (RoW)
- Middle East
Saudi Arabia
United Arab Emirates
Qatar
Israel
Rest of Middle East
- Africa
South Africa
Egypt
Morocco
Rest of Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations

2 Research Framework

2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
- 2.4.1 Data Collection (Primary and Secondary)
- 2.4.2 Data Modeling and Estimation Techniques
- 2.4.3 Data Validation and Triangulation
- 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

4.1 Porter's Five Forces Analysis
- 4.1.1 Supplier Bargaining Power
- 4.1.2 Buyer Bargaining Power
- 4.1.3 Threat of Substitutes
- 4.1.4 Threat of New Entrants
- 4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison

5 Global Biosensors Market, By Product Type

5.1 Wearable biosensors
5.2 Non-wearable biosensors
5.3 Implantable biosensors

6 Global Biosensors Market, By Biological Recognition Element

6.1 Enzymatic biosensors
6.2 Non-enzymatic biosensors
6.3 DNA biosensors
6.4 Immunosensors
6.5 Microbial biosensors

7 Global Biosensors Market, By Technology

7.1 Electrochemical biosensors
7.2 Optical biosensors
7.3 Piezoelectric biosensors
7.4 Thermal biosensors
7.5 Nanomechanical biosensors

8 Global Biosensors Market, By Application

8.1 Medical applications
8.2 Food and beverage testing
8.3 Environmental monitoring
8.4 Agriculture
8.5 Biodefense and security

9 Global Biosensors Market, By End User

9.1 Hospitals and clinics
9.2 Diagnostic laboratories
9.3 Home healthcare
9.4 Research and academic institutes
9.5 Pharmaceutical and biotechnology companies

10 Global Biosensors Market, By Geography

10.1 North America
- 10.1.1 United States
- 10.1.2 Canada
- 10.1.3 Mexico
10.2 Europe
- 10.2.1 United Kingdom
- 10.2.2 Germany
- 10.2.3 France
- 10.2.4 Italy
- 10.2.5 Spain
- 10.2.6 Netherlands
- 10.2.7 Belgium
- 10.2.8 Sweden
- 10.2.9 Switzerland
- 10.2.10 Poland
- 10.2.11 Rest of Europe
10.3 Asia Pacific
- 10.3.1 China
- 10.3.2 Japan
- 10.3.3 India
- 10.3.4 South Korea
- 10.3.5 Australia
- 10.3.6 Indonesia
- 10.3.7 Thailand
- 10.3.8 Malaysia
- 10.3.9 Singapore
- 10.3.10 Vietnam
- 10.3.11 Rest of Asia Pacific
10.4 South America
- 10.4.1 Brazil
- 10.4.2 Argentina
- 10.4.3 Colombia
- 10.4.4 Chile
- 10.4.5 Peru
- 10.4.6 Rest of South America
10.5 Rest of the World (RoW)
- 10.5.1 Middle East
  - 10.5.1.1 Saudi Arabia
  - 10.5.1.2 United Arab Emirates
  - 10.5.1.3 Qatar
  - 10.5.1.4 Israel
  - 10.5.1.5 Rest of Middle East
- 10.5.2 Africa
  - 10.5.2.1 South Africa
  - 10.5.2.2 Egypt
  - 10.5.2.3 Morocco
  - 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

11.1 Industry Value Network and Supply Chain Assessment
11.2 White-Space and Opportunity Mapping
11.3 Product Evolution and Market Life Cycle Analysis
11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

12.1 Mergers and Acquisitions
12.2 Partnerships, Alliances, and Joint Ventures
12.3 New Product Launches and Certifications
12.4 Capacity Expansion and Investments
12.5 Other Strategic Initiatives

13 Company Profiles

13.1 Abbott Laboratories
13.2 F. Hoffmann-La Roche Ltd
13.3 Medtronic plc
13.4 Siemens Healthineers AG
13.5 Danaher Corporation
13.6 Thermo Fisher Scientific Inc
13.7 Nova Biomedical Corporation
13.8 Bio-Rad Laboratories Inc
13.9 AgaMatrix Inc
13.10 Dexcom Inc
13.11 Ascensia Diabetes Care Holdings AG
13.12 ARKRAY Inc
13.13 LifeScan Inc
13.14 Senseonics Holdings Inc
13.15 Biosensors International Group Ltd

簡介目錄圖表

List of Tables

Table 1 Global Biosensors Market Outlook, By Region (2023-2034) ($MN)
Table 2 Global Biosensors Market Outlook, By Product Type (2023-2034) ($MN)
Table 3 Global Biosensors Market Outlook, By Wearable Biosensors (2023-2034) ($MN)
Table 4 Global Biosensors Market Outlook, By Non-Wearable Biosensors (2023-2034) ($MN)
Table 5 Global Biosensors Market Outlook, By Implantable Biosensors (2023-2034) ($MN)
Table 6 Global Biosensors Market Outlook, By Biological Recognition Element (2023-2034) ($MN)
Table 7 Global Biosensors Market Outlook, By Enzymatic Biosensors (2023-2034) ($MN)
Table 8 Global Biosensors Market Outlook, By Non-Enzymatic Biosensors (2023-2034) ($MN)
Table 9 Global Biosensors Market Outlook, By DNA Biosensors (2023-2034) ($MN)
Table 10 Global Biosensors Market Outlook, By Immunosensors (2023-2034) ($MN)
Table 11 Global Biosensors Market Outlook, By Microbial Biosensors (2023-2034) ($MN)
Table 12 Global Biosensors Market Outlook, By Technology (2023-2034) ($MN)
Table 13 Global Biosensors Market Outlook, By Electrochemical Biosensors (2023-2034) ($MN)
Table 14 Global Biosensors Market Outlook, By Optical Biosensors (2023-2034) ($MN)
Table 15 Global Biosensors Market Outlook, By Piezoelectric Biosensors (2023-2034) ($MN)
Table 16 Global Biosensors Market Outlook, By Thermal Biosensors (2023-2034) ($MN)
Table 17 Global Biosensors Market Outlook, By Nanomechanical Biosensors (2023-2034) ($MN)
Table 18 Global Biosensors Market Outlook, By Application (2023-2034) ($MN)
Table 19 Global Biosensors Market Outlook, By Medical Applications (2023-2034) ($MN)
Table 20 Global Biosensors Market Outlook, By Food and Beverage Testing (2023-2034) ($MN)
Table 21 Global Biosensors Market Outlook, By Environmental Monitoring (2023-2034) ($MN)
Table 22 Global Biosensors Market Outlook, By Agriculture (2023-2034) ($MN)
Table 23 Global Biosensors Market Outlook, By Biodefense and Security (2023-2034) ($MN)
Table 24 Global Biosensors Market Outlook, By End User (2023-2034) ($MN)
Table 25 Global Biosensors Market Outlook, By Hospitals and Clinics (2023-2034) ($MN)
Table 26 Global Biosensors Market Outlook, By Diagnostic Laboratories (2023-2034) ($MN)
Table 27 Global Biosensors Market Outlook, By Home Healthcare (2023-2034) ($MN)
Table 28 Global Biosensors Market Outlook, By Research and Academic Institutes (2023-2034) ($MN)
Table 29 Global Biosensors Market Outlook, By Pharmaceutical and Biotechnology Companies (2023-2034) ($MN)